NCHECRNational Centre in HIV Epidemiology and Clinical Research (Australia)
References in periodicals archive ?
Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis, Hepatitis C Sub-Committee, Hepatitis C Virus Projection Working Group, NCHECR, The University of New South Wales: Sydney, Australia.
In the study, Anadis' BioGard will be used alone and in combination with the new Merck (NYSE: MRK) anti-AIDS drug Isentress[TM] (raltegravir) This investigator initiated "CORAL" study is sponsored by NCHECR.
Australian survey research has observed that the proportion of people who inject drugs (PWID) and who share equipment varies, but can be as low as seven to 15% among those recruited from needle and syringe programs (Stafford, Sindicich, & Burns, 2008; NCHECR, 2009b) but higher among those from regional areas (Day, Conroy, Lowe, Page, & Dolan, 2006), and up to 30% among PWID who are recruited from pharmacies (Bryant et al.